AI Article Synopsis
- The goal of adjuvant hormone therapy for breast cancer is to match the effectiveness seen in clinical trials during everyday treatment.
- Despite its proven benefits, many patients struggle to consistently adhere to the therapy, highlighting compliance as a complex issue.
- By investigating the causes of non-compliance, we hope to identify at-risk patients and develop strategies to enhance adherence to hormone therapy.
Article Abstract
The aim of adjuvant hormone therapy for breast cancer is to reach, in daily practice, an efficacy similar to that obtained in clinical trials. In spite of the demonstrated efficacy of hormone therapy, compliance represents a major challenge and a multidimensional problem. A better understanding of the reasons underlying non-compliance would help identify the patients at higher risk and would permit the implementation of strategies to improve compliance to adjuvant hormone therapy. With this in mind, we undertook a review of the recent literature on the topic (Pub Med 2003-2009).
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
hormone therapy
12
therapy breast
8
adjuvant hormone
8
[adherence long-term
4
long-term medication
4
medication case
4
case adjuvant
4
adjuvant endocrine
4
therapy
4
endocrine therapy
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!